FDA sets March deadline for abortion pill safety review
The FDA expects to obtain results from a major safety study by mid-December, with a final report completed no later than March. Only then will the agency determine whether changes to its existing regulations are necessary.
Republican Ledger staff · 8:00 PM ET

Our newsroom is writing this report…
The FDA expects to obtain results from a major safety study by mid-December, with a final report completed no later than March. Only then will the agency determine whether changes to its existing regulations are necessary.
Recommended Stories
Trending nowRepublican backlash brews over Trump’s diesel deal with Russia
President Donald Trump’s decision to allow Russia to supply diesel fuel to the United States and global markets triggered pushback from multiple Republican figures on Saturday. Rep. Brian Fitzpatrick (R-PA) said he will introduce bipartisan
Republican Ledger staff · 11:22 PM ET
EconomyDavid Ellison’s Skydance deal was approved — but it may not be smooth sailing
With $80 billion in debt and a sprawling media empire to combine, David Ellison will have his hands full with the now court-approved combination of Paramount and Warner Bros Discovery, known as Skydance.
Republican Ledger staff · 10:00 PM ET
PoliticsSophie Cunningham Responds to Athletic Columnist Urging Fever to Trade Her Over Trans Comments: ‘Suck It’
WNBA guard Sophie Cunningham answered an Athletic column calling for the Indiana Fever to let her walk this offseason with a two-word reply on her podcast: “Suck it.” The unrestricted free agent, who averaged fewer than eight points a game
Republican Ledger staff · 9:39 PM ET
PoliticsRubio Deputy Calls Out Obama Ambassador’s ‘Smug’ Dismissal of Secretary’s Foreign Travel
Deputy Secretary of State Christopher Landau hit back Saturday after former Obama ambassador Ivo Daalder criticized Secretary of State Marco Rubio’s foreign travel. The post Rubio Deputy Calls Out Obama Ambassador’s ‘Smug’ Dismissal of Secr
Republican Ledger staff · 9:27 PM ET
Reader Discussion
0 comments- Loading comments…
